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Abstract 
c-AMP dependent protein kinase (protein kinase A, PKA) is an important enzyme involved in the 
regulation of an increasing number of physiological processes including immune function, cardiovascular 
disease, memory disorders and cancer. The objective of this study was to evaluate the PKA inhibitory 
activity of a range of algal extracts, along with their fatty acid composition. Six algal species were 
investigated including two Chlorophyta (Codium dimorphum and Ulva lactuca), two Phaeophyta 
(Phyllospora comosa and Sargassum sp.) and two Rhodophyta (Prionitis linearis and Corallina 
vancouveriensis), with the order of PKA inhibitory activity of their extracts identified as follows: brown 
seaweeds > red seaweeds > green seaweeds with the brown alga Sargassum sp. exhibiting the highest 
PKA inhibitory activity (84% at 100 microg/mL). GC/MS analysis identified a total of 18 fatty acids in the 
six algal extracts accounting for 72-87% of each extract, with hexadecanoic acid and 
9,12-octadecadienoic acid as the dominant components. The most active extract (Sargassum sp.) also 
contained the highest percentage of the saturated C14:0 fatty acid (12.8% of the total extract), which is a 
known to inhibit PKA. These results provide the first description of the PKA inhibitory activity of marine 
algae along with the first description of the fatty acid composition of these six algal species from South 
Eastern Australian waters. Importantly, this study reveals that abundant and readily available marine algae 
are a new and relatively unexplored source of PKA inhibitory compounds. 
Keywords 
kinase, protein, dependent, fatty, amp, composition, c, their, acid, australia, eastern, south, extracts, algal, 
six, activity, inhibitory, CMMB 
Disciplines 
Medicine and Health Sciences | Social and Behavioral Sciences 
Publication Details 
Zivanovic, A. & Skropeta, D. (2012). c-AMP dependent protein kinase A inhibitory activity of six algal 
extracts from South Eastern Australia and their fatty acid composition. Natural Product Communications: 
an international journal for communications and reviews, 7 (7), 923-926. 





c-AMP Dependent protein kinase A inhibitory activity of six algal 
extracts from South Eastern Australia and their fatty acid 
composition 
 
Ana Zivanovica and Danielle Skropeta a,b,* 
 
a School of Chemistry, University of Wollongong, NSW, 2500, Australia 
 








c-AMP Dependent protein kinase (protein kinase A, PKA) is an important enzyme involved in the regulation of an increasing number of physiological 
processes including immune function, cardiovascular disease, memory disorders and cancer. The objective of this study was to evaluate the PKA inhibitory 
activity of a range of algal extracts, along with their fatty acid composition. Six algal species were investigated including two Chlorophyta (Codium 
dimorphum and Ulva lactuca), two Phaeophyta (Phyllospora comosa and Sargassum sp.) and two Rhodophyta (Prionitis linearis and Corallina 
vancouveriensis), with the order of PKA inhibitory activity of their extracts identified as follows: brown seaweeds > red seaweeds > green seaweeds with the 
brown alga Sargassum sp. exhibiting the highest PKA inhibitory activity (84% at 100 μg/mL). GC/MS analysis identified a total of 18 fatty acids in the six 
algal extracts accounting for 72-87% of each extract, with hexadecanoic acid and 9,12-octadecadienoic acid as the dominant components. The most active 
extract (Sargassum sp.) also contained the highest percentage of the saturated C14:0 fatty acid (12.8% of the total extract), which is a known to inhibit PKA. 
These results provide the first description of the PKA inhibitory activity of marine algae along with the first description of the fatty acid composition of these 
six algal species from South Eastern Australian waters. Importantly, this study reveals that abundant and readily available marine algae are a new and relatively 
unexplored source of PKA inhibitory compounds. 
 




Kinases play a key role in cell regulation and their deregulation is a 
hallmark of a number of diseases including cancer [1]. PKA has 
received increasing attention in recent years as it is found to play a 
vital role in a myriad of physiological processes [2], in particular 
immune function [3] and memory disorders such as Alzheimer’s 
and Parkinson’s disease [4], where it has become an attractive new 
drug target. Interestingly, there are as yet no PKA inhibitors 
reported from any marine sources.  
 
Marine algae are well known as rich sources of bioactive natural 
products of diverse chemical structures and with a great range of 
biological activities [5]. The nutritional value of marine algae is 
also of importance as they have a high content of vitamins and 
minerals and are an important source of essential fatty acids (FAs) 
[6,7]. Marine algae contain a complex mixture of fatty acids of 
greater variety than those found in vascular plants [8] and are 
particularly rich in polyunsaturated fatty acids (PUFAs) [9]. Fatty 
acids are important for a wide array of cell structure components 
and for many biological, physiological and chemical processes in 
the body [7]. Biochemical analysis, in particular fatty acid 
composition, has been used for the taxonomic classification of 
various algal species [6,9]. Marine algae are also rich in 
halogenated compounds, polyphenols and polysaccharides, which 
display a wide range of activities including anticoagulant, antiviral, 
antioxidative, anticancer and immunomodulating activities [10]. A 
number of promising anticancer compounds are derived from algae 
including stypoldione from the brown alga Stypopodium zonale, 
which inhibits polymerization of microtubules, and the cytotoxic 
dehydrothysiferol isolated from the red alga Laurencia viridis, 
active against a number of human breast cancer cell lines [11]. 
 
Given the impressive bioactivity profiles of algal metabolites, the 
aim of the present work was to screen a range of algal extracts for 
their ability to inhibit PKA, along with obtaining their fatty acid 
profiles. The green seaweeds Codium dimorphum and Ulva lactuca, 
the brown seaweeds Phyllospora comosa and Sargassum sp. and the 
red seaweeds Prionitis linearis and Corallina vancouveriensis, were 
collected from two locations along the New South Wales coast of 
Australia known to be ‘biodiversity hotspots’ [12]. The six algal 
species investigated were chosen due to their high abundance in the 
collection area, their accessibility and as these species had not been 
studied previously from South Eastern Australian waters.  
Table 1. Algal species collected, class, collection place and % PKA inhibitory activity. 
No Algal species Class Collection Place Latitude Longitude % PKA inhibition 
1 Codium dimorphum Chlorophyta Belambi Point, NSW 34º 21' S 150º 56' E 28 ± 0.4 
2 Ulva lactuca  Chlorophyta Austinmer, NSW 34º 18' S 150º 56' E 18 ± 3.0 
3 Phyllospora comosa Phaeophyta Belambi Point, NSW 34º 21' S 150º 56' E 55 ± 1.6 
4 Sargassum sp. Phaeophyta Austinmer, NSW 34º 18' S 150º 56' E 84 ± 5.3 
5 Prionitis linearis Rhodophyta Austinmer, NSW 34º 18' S 150º 56' E 37 ± 3.4 
6 Corallina vancouveriensis Rhodophyta Austinmer, NSW 34º 18' S 150º 56' E 30 ± 1.1 
† All samples were collected from the South Eastern region of New South Wales (NSW), Australia. All measurements were performed in triplicate at a final concentration 
of 100 μg/mL. Biological data are presented as the mean values ± S.E.M from triplicate measurements. 
The highest PKA inhibitory activities were displayed by the 
dichloromethane extracts of the two brown algae Sargassum sp. and 
P. comosa (with 84% and 55% inhibition, respectively). The two 
red algal species, P. linearis and C. vancouveriensis, displayed 
 
 
similar activities of 38% and 30% respectively, while the two green 
algal dichloromethane extracts showed <30% activity. A small 
number of algal-derived kinase inhibitors have been described 
previously including the tyrosine kinase inhibitor stypoquinonic 
acid from the brown algae Stypopodium zonale; sulfated 
triterpenoids from the green algae Tuemoya sp. as tyrosine kinase 
Tie2 inhibitors; and cycloartanol derivatives from the green algae 
Tydemania expeditionis as inhibitors of pp60v-src [13]. However, this 
is the first report of marine algal extracts exhibiting PKA inhibitory 
activity and suggests that they may be an important new source of 
PKA inhibitors in the future. 
 
A total of 18 different fatty acids were identified in the samples 
comprising six saturated and eleven unsaturated straight chain fatty 
acids and one branched fatty acid. The GC-MS analysis of the six 
algal extracts identified hexadecanoic acid and 9,12-
octadecadienoic acid as the dominant fatty acids. Hexadecanoic 
acid was the main acid in five of the six samples (ranging from 
23.3-32.1% of the total extract), whilst only in C. dimorphum the 
major acid was 9,12-octadecadienoic acid (22.4%), followed by 
hexadecanoic acid (20.6%). The percentages of these two fatty 
acids were significantly higher than the amount of the other 
compounds in all extracts. These results are consistent with 
previous reports where hexadecanoic acid was identified in high 
percentages in various algal species including U. lactuca from 
China [6], U. fenestrata from Japan [14]; Sargassum sp. from Japan 
[7,15]; P. linearis from California [16]; Corallina granifera from 
the Black Sea [17], C. dimorphum from Chile [8], and Phyllospora 
comosa from Tasmania, Australia [18]. 
 
Some similarity was observed in the fatty acid composition of the 
six algal species. For example, U. lactuca, P. comosa and C. 
vancouveriensis had similar fatty acid compositions with only small 
differences in the type and relative percentages of some acids. The 
highest number of identified fatty acids (18 fatty acids), was found 
in the red algae C. vancouveriensis, followed by 17 fatty acids in 
the brown algae P. comosa, with the lowest number (10 fatty acids), 
found in the green algae C. dimorphum. PUFAs of C18, C20 and C22 
chain length were detected among the six species but only in low 
overall percentages. C. vancouveriensis and P. comosa contained 
the highest proportion of PUFAs (10.7% and 10.1% respectively), 
while a lower number were found in the Sargassum sp, U. lactuca 
and P. linearis and no PUFAs were detected at all in C. dimorphum. 
The ratio of saturated: unsaturated acids varied from 1:2 in Codium 
dimorphum and Phyllospora comosa to 1:1 in all others. The fatty 
acid compositions of some of the species investigated herein have 
been described previously [7,8,15,18,19], however this is the first 
report of the fatty acid composition of these species collected from 
South Eastern Australian waters, and the first description of the 
PKA inhibitory activity of any marine algal extracts.  
 
As fatty acids accounted for the major part of the extracts examined 
(i.e. 72-87% of the total extract), it is likely that they are responsible 
for, or at least contribute in part to, the observed PKA inhibitory 
activity of the extracts. ω-Fatty acids have been reported to inhibit 
related protein kinases such as PKC [21]. Furthermore, previous 
studies in our group [20] have shown that the saturated fatty acid 
C14:0 shows strong PKA inhibitory activity, and C16:0, C18:0 and 
C18:1 fatty acids moderate activity at the same concentration as that 
used herein (100 µg/mL). Interestingly, the most active algal 
extract, that of the Sargassum sp., also contained the highest 
percentage (12.8%) of the more potent PKA inhibitory C14:0 fatty 
acid. The Prionitis linearis extract, which showed only moderate 
PKA inhibitory activity, had the highest proportion (32.1%) of the 
C16:0 fatty acid, which is known to inhibit PKA at a similar 
moderate level of activity [20]. It should, however, also be noted 
that the remainder of the non-polar extract examined comprised 
aldehydes, hydrocarbons and alcohols, which could also contribute 




Table 2: Fatty acid composition of the dichloromethane extracts from the SE Australian marine algae 
   Chlorophyta Phaeophyta Rhodophyta 
No. Fatty acids Type 1 2 3 4 5 6 
1 Tetradecanoic acid  14:0 2.1 6.0 5.4 12.8 4.0 5.8 
2 12-Methyltetradecanoic acid  15:0 0.7 0.3 - - - 0.1 
3 Hexadecanoic acid 16:0 20.6 25.5 23.3 23.3 32.1 24.9 
4 7-Hexadecenoic acid  16:1 n-9 - - 0.1 - - 0.2 
5 9-Hexadecenoic acid  16:1 n-7 15.4 3.5 4.4 3.6 6.3 2.3 
6 Heptadecanoic acid  17:0 - 1.2 1.7 0.3 - 0.5 
7 Octadecanoic acid  18:0 2.3 0.4 0.5 1.9 2.3 1.2 
8 9-Octadecenoic acid  18:1 n-9 7.2 3.1 4.5 4.4 2.2 8.8 
9 9,12-Octadecadienoic acid 18:2 n-6 22.4 14.9 20.0 16.5 26.7 19.3 
10 6,9,12-Octadecatrienoic acid 18:3 n-6 1.9 0.7 0.4 1.2 1.8 0.9 
11 6,9,12,15-Octadecatetranoic acid 18:4 n-3 - 0.3 0.4 - - 0.1 
12 Eicosanoic acid  20:0 - tr 0.1 - - 0.4 
13 11,14-Eicosadienoic acid  20:2 n-6 5.8 8.8 14.3 8.3 7.0 6.2 
14 8,11,14-Eicosatrienoic acid  20:3 n-6 4.8 4.7 5.4 11.3 4.2 5.2 
15 5,8,11,14-Eicosatetraenoic acid 20:4 n-6 - 0.9 1.4 0.5 0.9 0.5 
16 5,8,11,14,17-Eicosapentaenoic acid  20:5 n-3 - 1.3 0.7 1.7 1.1 1.6 
17 7,10,13,16,19-Docosapentaenoic acid  22:5 n-3 - - 0.1 - - 0.1 
18 Tricosanoic acid  23:0 - - 0.2 0.2 - 0.3 
 % of Total extract  83.2 71.6 82.9 86.0 88.6 78.4 
Six algae species analysed: 1: Codium dimorphum; 2:  Ulva lactuca; 3: Phyllospora comosa; 4: Sargassum sp.; 5:  Prionitis linearis ; 6: Corallina 





In summary, as part of a wider screening program aimed at 
identifying novel therapeutic agents from Australian marine fauna, 
 
 
a range of algae from SE Australia were screened for PKA 
inhibitory activity, with the most potent activity (84% at 100 
µg/mL) exhibited by the brown alga Sargassum sp. The biological 
activity of the algal extracts was reflected in the different algal 
divisions, with the order of PKA inhibitory activity identified as: 
brown seaweeds > red seaweeds > green seaweeds. The fatty acid 
composition of all six algal species investigated was dominated by 
hexadecanoic and 9,12-octadecadienoic acid and comprised a 2:1 to 
1:1 ratio of unsaturated:saturated fatty acids. Some of these fatty 
acids are likely to contribute to the observed PKA inhibitory 
activities of the algal extracts and their further investigation is 




Collection: A summary of the species collected, taxonomic class, 
and collection place is provided in Table 1. The algae were 
collected from the intertidal zone by hand during the period 
March/April 2008 under Scientific Research Permit Number 
F95/269-4.0 issued by the New South Wales (NSW) Department of 
Fisheries, Australia and stored frozen (-20 °C) until extraction. 
Voucher specimens are held at the University of Wollongong, 
NSW, Australia (AZ061, AZ073, AZ056, AZ072, AZ076, and 
AZ077). 
 
Extract Preparation: The frozen algal tissue was macerated and 
exhaustively extracted with CH2Cl2 (20-50 ml / g tissue) and then 
MeOH. The solvents were combined and removed in vacuo at 30 
°C. The crude extract was then extracted with CH2Cl2 to yield 0.3-
4.6 g of CH2Cl2-soluble material upon evaporation that was 
subjected to GC and GC/MS analyses. Stock solutions of 1mg/mL 
of the CH2Cl2-extract were prepared in 20% DMSO and further 
diluted by 1:10 in the assay to give a final concentration of 
100 µg/mL (in 2% DMSO).   
 
GC: GC Analyses were performed on a Shimadzu GC-2100 Plus 
system equipped with a BP-5 fused silica Rxi-5ms capillary column 
(5% phenyl/95% dimethyl polysiloxane, 30 m x 0.25 mm, 0.25 μm 
film thickness, Restek), using hydrogen carrier gas (1.0 mL/mn) and 
samples of 1 μL . The oven was programmed at 40 °C at 4 °C per 
minute to 290 °C and held at 290 °C for 5 minutes.  
 
GC/MS: GC/MS Analyses were performed on a Shimadzu QP-
5050A GC-MS system with a mass selective detector operated in 
the EI mode (70 eV0) and equipped with a BP-5 fused silica Rxi-
5ms capillary column (5% phenyl/95% dimethyl polysiloxane, 30 m 
x 0.25 mm, 0.25 μm film thickness, Restek), using helium carrier 
gas (1.0 mL/mn) and samples of 1 μL over the temperature range 
80-300 °C. The relative intensity of each peak was calculated as a 
percentage of the summed total. Fatty acids were detected as their 
methyl esters after treatment with methanolic boron trifluoride and 
their identification was based on comparisons of the mass spectral 
fragmentation patterns to the NIST 08 mass spectral database and 
comparison with authentic standards where possible. Replicate 
GC/MS analyses performed on samples gave identical results. 
 
Biological Activity: PKA inhibitory activity was determined using 
the Kinase-Glo® Luminescent Kinase Assay (Promega Corporation, 
Madison, USA). Each well of an opaque white 96 well plate 
(Corning) contained 5 µl of sample, 25 µl of ATP (20 µM), and 20 
µl of a mixture of kinase (0.1unit/µL) and Kemptide substrate (140 
µM) in reaction buffer (40 mM Tris, 20mM MgCl2, BSA 
0.1mg/mL, pH 7.4). After 1 hr incubation at RT, 50 µL of the 
Kinase-Glo® Reagent was added, the mixture incubated for 15 mn 
and luminescence measured on a BMG Labtech FLUOstar Optima® 
luminometer. Data were determined relative to positive controls that 
contained solvent in place of sample. Negative controls contained 
no substrate. Staurosporine (IC50 = 7 nM) was used as an internal 
standard. All measurements were performed in triplicate and in at 
least two independent experiments for reproducibility. Data are 
presented as the mean values ± S.E.M. 
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